As an integral part of any business, an experienced Board and suite of appropriately equipped Non-Executives, serve well to guide an organisation on the most positive of paths. Within the broad space that the Life Science industry exists, a well-balanced Board is even more poignant, with governance, expert technical advice and scientific or medical oversight, all of the utmost importance.
At PIR International, we are trusted by our clients to access an established network of international Non-Executive profiles and advisors to help build versatile and nimble Boards.
Case Studies
CellCentric
Independent Non-Executive Director CellCentric is an innovative clinical-stage biotechnology company pioneering p300/CBP drug development. Spun out from the University of Cambridge, its lead asset, inobrodib, is a potential first-in-class orally bioavailable P300/CBP inhibitor being developed for multiple myeloma and other [...]
Dynamic42
Executive Chair Established in 2018, Dynamic42 is an innovative growth stage life science research tools company developing advanced three-dimensional organ-on-chip technology for preclinical research and development for the pharmaceutical, biotechnology and academic research sectors. Headquartered in Jena, Germany, with a [...]
Sibylla Biotech
Non-Executive Chair Seed-invested in 2019, and headquartered in Milan, Sibylla Biotech is a dynamic early-stage biotechnology company pioneering a disruptive approach to drug discovery. Its innovative platform technology leverages protein folding interference as a new therapeutic modality against undruggable or [...]
Monument Therapeutics
Non-Executive Chair Advisory Board Member A spin-out of Cambridge Cognition in 2021, Monument Therapeutics (Monument Tx) is an independent UK based biotech, developing products to treat serious diseases of the central nervous system. Specialists in the use of validated digital [...]
Closed Loop Medicine
Non-Executive Chair Closed Loop Medicine is a TechBio company leveraging AI, machine learning, and personalised dosing to enhance drug development, with the aim of redefining precision medicine. The Company’s proprietary technology platform facilitates personalised drug dosing optimisation, through integration of [...]
Anaveon
Non-Executive Chair Anaveon is a Switzerland based global clinical stage biopharmaceutical company specialising in the development of treatments for diseases with immune system dysfunction. The company is focused on developing biologics to modulate the function of cytokines with the potential [...]
